BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26555472)

  • 41. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice.
    Zhao Y; Dai XY; Zhou Z; Zhao GX; Wang X; Xu MJ
    Acta Pharmacol Sin; 2016 Feb; 37(2):196-203. PubMed ID: 26687933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.
    Barbosa SP; Lins LC; Fonseca FA; Matos LN; Aguirre AC; Bianco HT; Amaral JB; França CN; Santana JM; Izar MC
    Life Sci; 2013 May; 92(14-16):845-51. PubMed ID: 23507424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
    Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
    J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of atorvastatin and ezetimibe treatment on serum lipid profile and oxidative state in rats fed with a high-cholesterol diet.
    Yasim A; Ozbag D; Kilinc M; Ciralik H; Toru H; Gümüşalan Y
    Am J Med Sci; 2010 May; 339(5):448-52. PubMed ID: 20224310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent.
    Azar M; Valentin E; Badaoui G; Kassab R; Sarkis A; Azar RR
    Am J Cardiol; 2011 Jun; 107(11):1571-4. PubMed ID: 21439529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice.
    Pouwer MG; Pieterman EJ; Worms N; Keijzer N; Jukema JW; Gromada J; Gusarova V; Princen HMG
    J Lipid Res; 2020 Mar; 61(3):365-375. PubMed ID: 31843957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.
    Canault M; Peiretti F; Poggi M; Mueller C; Kopp F; Bonardo B; Bastelica D; Nicolay A; Alessi MC; Nalbone G
    J Pathol; 2008 Apr; 214(5):574-83. PubMed ID: 18247429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of macrophage-derived foam cell formation by ezetimibe via the caveolin-1/MAPK pathway.
    Qin L; Yang YB; Yang YX; Zhu N; Liu Z; Ni YG; Li SX; Zheng XL; Liao DF
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):182-92. PubMed ID: 26666965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.
    Van Rooyen DM; Gan LT; Yeh MM; Haigh WG; Larter CZ; Ioannou G; Teoh NC; Farrell GC
    J Hepatol; 2013 Jul; 59(1):144-52. PubMed ID: 23500152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The important role of apolipoprotein A-II in ezetimibe driven reduction of high cholesterol diet-induced atherosclerosis.
    Yan Y; He F; Li Z; Xu R; Li T; Su J; Liu X; Zhao M; Wu W
    Atherosclerosis; 2019 Jan; 280():99-108. PubMed ID: 30500605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. All-trans retinoic acid effectively reduces atheroma plaque size in a rabbit model of high-fat-induced atherosclerosis.
    Zarei L; Bahrami M; Farhad N; Froushani SMA; Abbasi A
    Adv Clin Exp Med; 2018 Dec; 27(12):1631-1636. PubMed ID: 30048051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-/- mice via reducing lipid uptake and vascular inflammation.
    Yu Z; Peng Q; Li S; Hao H; Deng J; Meng L; Shen Z; Yu W; Nan D; Bai Y; Huang Y
    Clin Sci (Lond); 2020 Mar; 134(5):439-458. PubMed ID: 32091078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
    Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP;
    Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compound K Attenuates the Development of Atherosclerosis in ApoE(-/-) Mice via LXRα Activation.
    Zhou L; Zheng Y; Li Z; Bao L; Dou Y; Tang Y; Zhang J; Zhou J; Liu Y; Jia Y; Li X
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [An inhibitor of intestinal cholesterol transporter].
    Sano M
    Nihon Rinsho; 2013 Sep; 71(9):1661-6. PubMed ID: 24205731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic Internal Exposure to Low Dose 137Cs Induces Positive Impact on the Stability of Atherosclerotic Plaques by Reducing Inflammation in ApoE-/- Mice.
    Le Gallic C; Phalente Y; Manens L; Dublineau I; Benderitter M; Gueguen Y; Lehoux S; Ebrahimian TG
    PLoS One; 2015; 10(6):e0128539. PubMed ID: 26046630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.